MedTrace Logo

Effects of Topical Gentamicin on the Prevention of Peritoneal Dialysis Related Infection

NCT05251584 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-02-22

No results posted yet for this study

Summary

Peritoneal dialysis-related infection is a complication that leads to peritoneal dialysis catheter removal or patient death. The present study aimed to investigate peritoneal dialysis-related infection, causative pathogens resulting in topical 2% mupirocin ointments period compare with 0.1% gentamicin cream period. Rate of catheter removal, time to first peritoneal dialysis-related infection after apply gentamicin cream.

Conditions

  • Peritoneal Dialysis-related Infection

Interventions

DRUG

Mupirocin

Apply mupirocin ointments for prevention of peritoneal dialysis-related infection between 1 January 2021 to 31 December 2021

DRUG

Gentamicin

Apply gentamicin creams for prevention of peritoneal dialysis-related infection for 1 year start after 1 January 2022

Sponsors & Collaborators

  • Silpakorn University

    collaborator OTHER

  • Phramongkutklao College of Medicine and Hospital

    lead OTHER

Principal Investigators

  • Ittaprach Yimsuk, PharmD · College of Pharmacy, Rangsit university

  • Pamila Tasanavipas, MD · Phramongkutklao hospital and College of Medicine

  • Daraporn Rungprai, BCP · Faculty of Pharmacy, Silpakorn University

  • Wichai Santimaleeworagun, BCP · Faculty of Pharmacy, Silpakorn University

  • Kulthida Chaijumroen, B.N.S. · Phramongkutklao hospital and College of Medicine

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-01
Primary Completion
2023-03-31
Completion
2023-05-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05251584 on ClinicalTrials.gov